Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- PE ratio
- —
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 50,000
- Avg volume
- 62,404
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- 9%
- Beta
- —
- Analysts
- Strong Buy
- Price target
- —
Company profile
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated...
Show more
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 44 14 8368 5670
- Website
- https://www.futuramedical.com
- Address
- Surrey Technology Centre, 40 Occam Road, Guildford, United Kingdom
Latest news
No headlines yet.
